Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
19
|
| pubmed:dateCreated |
1996-3-7
|
| pubmed:abstractText |
Vaginal contraception (condom, diaphragm and spermicide in pessary, tablet, jelly, cream, or sponge form) have been little used in France and generally in Europe since the advent of modern contraception with "the pill" and the intrauterine contraceptive device. The former methods, when properly used, are nevertheless both effective and useful, at least as interim measures. In addition, the protection they afford against sexually transmitted diseases and, for the condom, against HIV, is not negligible. Finally, the "barrier" methods of contraception such as the diaphragm and the condom afford significant protection against cancer of the cervix. The intrauterine contraceptive device (IUCD), used in France by 14% of women between 15 and 49 years of age and by 90 million women throughout the world for whom it is the main reversible means of contraception, have a mechanism of action that is still not fully understood. Most IUCD now used are made of copper. There are also diffusion IUCD based on progesterone or a synthetic progestational hormone which are useful in case of anaemia, menorrhagia or dysmenorrhea.
|
| pubmed:keyword |
http://linkedlifedata.com/resource/pubmed/keyword/Barrier Methods,
http://linkedlifedata.com/resource/pubmed/keyword/Condom,
http://linkedlifedata.com/resource/pubmed/keyword/Contraception,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Effectiveness,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Methods,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Methods--side effects,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Mode Of Action,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Usage,
http://linkedlifedata.com/resource/pubmed/keyword/Developed Countries,
http://linkedlifedata.com/resource/pubmed/keyword/Europe,
http://linkedlifedata.com/resource/pubmed/keyword/Family Planning,
http://linkedlifedata.com/resource/pubmed/keyword/Female Condom,
http://linkedlifedata.com/resource/pubmed/keyword/France,
http://linkedlifedata.com/resource/pubmed/keyword/Iud--side effects,
http://linkedlifedata.com/resource/pubmed/keyword/Mediterranean Countries,
http://linkedlifedata.com/resource/pubmed/keyword/Method Acceptability,
http://linkedlifedata.com/resource/pubmed/keyword/Vaginal Barrier Methods,
http://linkedlifedata.com/resource/pubmed/keyword/Vaginal Spermicides,
http://linkedlifedata.com/resource/pubmed/keyword/Western Europe
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
F
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0035-2640
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
45
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2407-15
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:otherAbstract |
PIP: With the introduction of modern contraceptives (i.e., oral contraceptives and IUDs), women in France as well as those in Europe in general tend not to use vaginal contraceptives as their principal contraceptive method. Vaginal contraceptives include the condom, diaphragm, and spermicide in the form of a pessary, tablet, jelly, cream, or sponge. When vaginal contraceptives are used correctly, they have an acceptable efficacy and are useful, at least as interim methods. It is important to also consider their part in protecting against sexually transmitted diseases and HIV. Further, the vaginal barrier methods, the condom and the diaphragm, provide significant protection against cervical cancer. 14% of women aged 15-49 in France and 90 million women worldwide use the IUD. Worldwide, the IUD is the primary reversible contraceptive method used. The contraceptive mode of action of the IUD is not yet clearly understood. The most popular IUD is the copper-releasing IUD. The IUD releasing progesterone or a synthetic progestin is useful in treating anemia, menorrhagia, or dysmenorrhea.
|
| pubmed:meshHeading |
pubmed-meshheading:8571052-Administration, Intravaginal,
pubmed-meshheading:8571052-Contraceptive Agents,
pubmed-meshheading:8571052-Contraceptive Devices,
pubmed-meshheading:8571052-Female,
pubmed-meshheading:8571052-Humans,
pubmed-meshheading:8571052-Intrauterine Devices,
pubmed-meshheading:8571052-Male
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
[Vaginal and intrauterine contraception].
|
| pubmed:affiliation |
Centre de régulation des naissances Hôpital, Saint-Louis, Paris.
|
| pubmed:publicationType |
Journal Article,
English Abstract,
Review
|